Daan Gene Co., Ltd. (SHE:002030)

Daan Gene Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Jan 1, 2024	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	491.04	872.09	999.37	2,594	2,179	870.4
Short-Term Investments	-	858.76	1,310	485.37	-	-
Trading Asset Securities	396	63	90.08	480.9	380.01	888
Cash & Short-Term Investments	887.04	1,794	2,400	3,561	2,559	1,758
Cash Growth	-5.08%	-25.25%	-32.61%	39.15%	45.53%	557.84%
Accounts Receivable	822.78	1,318	2,170	4,247	2,352	1,541
Other Receivables	35.96	33.62	50	52.76	56.46	29.62
Receivables	858.74	1,461	2,353	4,445	2,525	1,867
Inventory	194.08	198.21	239.52	369.6	493.72	315.72
Other Current Assets	934.31	328.66	318.19	393.98	407.6	385.87
Total Current Assets	2,874	3,782	5,310	8,769	5,985	4,327
Property, Plant & Equipment	1,654	1,790	1,903	1,767	863.06	409.63
Long-Term Investments	1,603	2,537	2,517	3,070	2,703	1,345
Other Intangible Assets	525.71	572.72	279.7	204.12	115.03	99.56
Long-Term Accounts Receivable	89.18	87.47	35.91	72.05	16.62	54.49
Long-Term Deferred Tax Assets	404.97	358.39	228.9	199.34	112.69	66.22
Long-Term Deferred Charges	390.37	397.58	670.48	574.92	331.52	275.67
Other Long-Term Assets	1,533	34.39	57.21	99.95	209.08	102.87
Total Assets	9,094	9,577	11,018	14,757	10,336	6,700
Accounts Payable	192.81	357.87	425.44	737.07	553.01	474.92
Accrued Expenses	418.75	569.74	760.13	1,559	985.63	568.49
Short-Term Debt	97.54	143.53	330.8	117.76	282.59	222.44
Current Portion of Long-Term Debt	-	-	-	-	-	178.31
Current Portion of Leases	-	6.95	13.21	42.66	45.32	6.26
Current Income Taxes Payable	36.38	28.12	29.69	302	383.47	319.31
Current Unearned Revenue	48.37	66.23	34.23	69.34	152.45	193.65
Other Current Liabilities	145.83	121.3	127.58	140.9	118.58	101.07
Total Current Liabilities	939.68	1,294	1,721	2,969	2,521	2,064
Long-Term Leases	9.64	13.46	21.81	67.38	76.15	4.84
Long-Term Unearned Revenue	46.84	58.53	32.69	27.27	30.14	36.98
Long-Term Deferred Tax Liabilities	82.51	61.24	79.85	47.97	46.97	60.72
Other Long-Term Liabilities	20.6	6.93	5.41	29.8	2.17	18.38
Total Liabilities	1,099	1,434	1,861	3,141	2,676	2,185
Common Stock	1,403	1,403	1,403	1,403	1,403	877.15
Additional Paid-In Capital	603.66	600.97	651.54	719.99	621.38	674.03
Retained Earnings	5,741	5,883	6,829	9,181	5,326	2,717
Comprehensive Income & Other	-7.84	-7.41	-3.92	-2.85	0.5	0.88
Total Common Equity	7,741	7,880	8,880	11,301	7,351	4,269
Minority Interest	253.71	263.07	276.83	314.79	308.63	246.03
Shareholders' Equity	7,994	8,143	9,157	11,616	7,660	4,515
Total Liabilities & Equity	9,094	9,577	11,018	14,757	10,336	6,700
Total Debt	107.18	163.94	365.83	227.8	404.06	411.85
Net Cash (Debt)	779.86	1,630	2,034	3,333	2,155	1,347
Net Cash Growth	2.24%	-19.86%	-38.98%	54.66%	60.03%	-
Net Cash Per Share	0.55	1.16	1.36	2.37	1.54	0.96
Filing Date Shares Outstanding	1,403	1,403	1,403	1,403	1,403	1,403
Total Common Shares Outstanding	1,403	1,403	1,403	1,403	1,403	1,403
Working Capital	1,934	2,488	3,589	5,800	3,464	2,263
Book Value Per Share	5.52	5.61	6.33	8.05	5.24	3.04
Tangible Book Value	7,215	7,307	8,601	11,097	7,236	4,169
Tangible Book Value Per Share	5.14	5.21	6.13	7.91	5.16	2.97
Buildings	-	807.22	766.64	618.81	293.09	182.66
Machinery	-	1,141	1,155	1,017	591.94	446.04
Construction In Progress	-	776.1	727.35	576.63	210.65	45.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.